Abstract
The Latent Membrane Protein 1 (LMP-1) protein of Epstein-Barr virus (EBV) is localized in the plasma membrane of the infected cell. LMP-1 possesses a hydrophobic membrane spanning domain, and charged, intracellular amino- and carboxy-termini. Two models have been proposed for the contribution of the amino-terminus to LMP-1's function: (i) as an effector domain, interacting with cellular proteins, or (ii) as a structural domain dictating the correct orientation of transmembrane domains and thereby positioning LMP-1's critical effector domains (i.e. the carboxy-terminus). However, no studies to date have addressed directly the structural contributions of LMP-1's cytoplasmic amino-terminus to function. This study was designed to determine if LMP-1's cytoplasmic amino-terminus (N-terminus) encodes information required solely for maintenance of proper topological orientation. We have constructed LMP-1 chimeras in which the cytoplasmic N-terminus of LMP-1 is replaced with an unrelated domain of similar size and charge, but of different primary sequence. Retention of the charged amino-terminal (N-terminal) cytoplasmic domain and first predicted transmembrane domain was required for correct transmembrane topology. The absolute primary sequence of the cytoplasmic N-terminus was not critical for LMP-1's cytoskeletal association, turnover, plasma membrane patching, oligomerization, Tumor Necrosis Factor Receptor-associated factor (TRAF) binding, NF-κB activation, rodent cell transformation and cytostatic activity. Furthermore, our results point to the hydrophobic transmembrane domain, independent of the cytoplasmic domains, as the primary LMP-1 domain mediating oligomerization, patching and cytoskeletal association. The cytoplasmic amino-terminus provides the structural information whereby proper transmembrane orientation is achieved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aviel S, Winberg G, Massucci M, Ciechanover A . 2000 J. Biol. Chem. 275: 23491–23499
Baichwal VR, Sugden B . 1987 J. Virol. 61: 866–875
Baichwal VR, Sugden B . 1988 Oncogene 2: 461–467
Baichwal VR, Sugden B . 1989 Oncogene 4: 67–74
Bankier AT, Deininger PL, Satchwell SC, Baer R, Farrell PJ, Barrell BG . 1983 Mol. Biol. Med. 1: 425–445
Beltzer JP, Fiedler K, Fuhrer C, Geffen I, Handschin C, Wessels HP, Spiess M . 1991 J. Biol. Chem. 266: 973–978
Bloss T, Kaykas A, Sugden B . 1999 J. Gen. Virol. 80: 3227–3232
Bonifacino J, Lippincott-Schwartz J . 1991 Curr. Opin. Cell. Biol. 3: 592–600
Bonifacino J, Weissman A . 1998 Annual Review of Cell. and Dev. Biol. 14: 19–57
Brodeur SR, Cheng G, Baltimore D, Thorley-Lawson DA . 1997 J. Biol. Chem. 272: 1977–19784
Clausse B, Fizazi K, Walczak V, Tetaud C, Wiels J, Tursz T, Busson P . 1997 Virology 228: 285–293
Devergene O, Hatzivassiliou E, Izumi KM, Kaye K, Kleijnen MF, Kieff E, Mosialos G . 1998 J. Virol. 72: 7900–7908
Devergne O, Hatzivassiliou E, Izumi K, Kaye K, Kleijnen M, Kieff E, Mosialos G . 1996 Mol. Cell. Biol. 16: 7098–7108
Eliopoulos AG, Blake SS, Floettmann JE, Rowe M, Young LS . 1999 J. Virol. 73: 1023–1035
Eliopoulos AG, Rickinson AB . 1998 Curr. Biol. 8: R196–R198
Eliopoulos AG, Young LS . 1998 Oncogene 16: 1713–1742
Erickson KD, Martin JM . 2000 J. Virol. 74: 1057–1060
Fahreus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B . 1988 Int. J. Cancer 42: 329–338
Fennewald S, van SV, Kieff E . 1984 J. Virol. 51: 411–419
Floettmann JE, Rowe M . 1997 Oncogene 15: 1851–1858
Floettmann JE, Ward K, Rickinson AB, Rowe M . 1996 Virology 223: 29–40
Fries KL, Miller WE, Raab-Traub N . 1996 J. Virol. 70: 8653–8659
Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W . 1997 EMBO J. 16: 6131–6140
Gratama JW, Zutter MM, Minarovits J, Oosterveer MA, Thomas ED, Klein G, Ernberg I . 1991 Int. J. Cancer 47: 188–192
Gross JL, Krupp MN, Rifkin DB, Lane MD . 1983 Proc. Natl. Acad. Sci. USA 80: 2276–2280
Haigler HT, Ash JF, Singer SJ, Cohen C . 1978 Proc. Natl. Acad. Sci. USA 75: 5025–5029
Hammerschmidt W, Sugden B, Baichwal VR . 1989 J. Virol. 63: 2469–2475
Hammerskjold M, Simurda M . 1992 J. Virol. 66: 6496–6501
Hartmann E, Rapoport TA, Lodish HF . 1989 Proc. Natl. Acad. Sci. USA 86: 5786–5790
Hatzivassiliou E, Miller WE, Raab-Traub N, Kieff E, Mosialos G . 1998 J. Immunol. 160: 1116–1121
Hedge R, Lingappa V . 1997 Cell 28: 575–582
Hedge R, Lingappa V . 1999 Trends Cell. Biol. 9: 132–137
Huen DS, Henderson SA, Croom-Carter D, Rowe M . 1995 Oncogene 10: 549–560
Izumi KM, Kaye KM, Kieff E . 1994 J. Virol. 68: 4369–4376
Izumi KM, Kaye KM, Kieff ED . 1997 Proc. Natl. Acad. Sci. USA 94: 1447–1452
Izumi KM, Kieff ED . 1997 Proc. Natl. Acad. Sci. USA 94: 12592–12597
Izumi KM, McFarland EC, Ting AT, Riley EA, Seed B, Kieff ED . 1999 Mol. Cell Biol. 19: 5759–5767
Kaye K, Izumi K, Mosialos G, Kieff E . 1995 J. Virol. 69: 675–683
Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G . 1996 Proc. Natl. Acad. Sci. USA 93: 11085–11090
Kaye KM, Izumi KM, Kieff E . 1993 Proc. Natl. Acad. Sci. USA 90: 9150–9154
Kaykas A, Sugden B . 2000 Oncogene 19: 1400–1410
Kieser A, Kaiser C, Hammerschmidt W . 1999 EMBO J. 18: 2511–2521
Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W . 1997 EMBO J. 16: 6478–6485
Knutson VP, Ronnett GV, Lane MD . 1985 J. Biol. Chem. 260: 14180–14188
Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM . 1992 J. Biol. Chem. 34: 24157–24160
Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E . 1987 Mol. Cell. Biol. 7: 2299–2308
Liebowitz D, Mannick J, Takada K, Kieff E . 1992 J. Virol. 66: 4612–4616
Liebowitz D, Wang D, Kieff E . 1986 J. Virol. 58: 233–237
Lipp J, Dobberstein B . 1986 J. Cell. Biol. 102: 2169–2175
Mann KP, Staunton D, Thorley-Lawson D . 1985 J. Virol. 55: 710–720
Mann KP, Thorley-Lawson D . 1987 J. Virol. 61: 2100–2108
Martin JM, Sugden B . 1991a Cell Growth and Differentiation 2: 653–660
Martin JM, Sugden B . 1991b J. Virol. 65: 3246–3258
Martin JM, Veis D, Korsmeyer SJ, Sugden B . 1993 J. Virol. 67: 5269–5278
Miller G . 1985 Epstein-Barr Virus, 1 edn. Miller G (ed.) Raven Press, New York
Miller WE, Cheshire JL, Raab-Traub N . 1998 Mol. Cell. Biol. 18: 2835–2844
Mitchell T, Sugden B . 1995 J. Virol. 69: 2968–2976
Moorthy RK, Thorley-Lawson DA . 1993 J. Virol. 67: 1638–1646
Mosialos G, Birkenbach M, Yalamanchili R, Van Arsdale T, Ware C, Kieff E . 1995 Cell. 80: 389–399
Paine E, Scheinman RI, Baldwin Jr. AS, Raab-Traub N . 1995 J. Virol. 69: 4572–4576
Pallesen G, Hamilton-Dutolt SJ, Rowe M, Young IS . 1991 Lancet 337: 320–322
Parks GD, Lamb RA . 1991 Cell. 64: 777–787
Rabson M, Heston L, Miller G . 1983 Proc. Natl. Acad. Sci. USA 80: 2762–2766
Roberts ML, Cooper NR . 1998 Virology 240: 93–99
Sandberg M, Hammerschmidt W, Sugden B . 1997 J. Virol. 71: 4649–4656
Schlessinger J, Shechter Y, Willingham MC, Pastan I . 1978 Proc. Natl. Acad. Sci. USA 75: 2659–2663
Schmid SR, Spiess M . 1988 J. Biol. Chem. 263: 16886–16891
Spiess M, Lodish HF . 1986 Cell. 44: 177–185
Spiess M, Schwartz AL, Lodish HF . 1985 J. Biol. Chem. 260: 1979–1982
Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G . 1998 Proc. Natl. Acad. Sci. USA 95: 10106–10111
Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH . 1990 Transplantation 49: 944–953
Wang D, Liebowitz D, Kieff E . 1985 Cell 43: 831–840
Wang D, Liebowitz D, Kieff E . 1988a J. Virol. 62: 2337–2346
Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E . 1988b J. Virol. 62: 4173–4184
Yarden Y, Ullrich A . 1988 Annu. Rev. Biochem. 57: 443
Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI . 1989 N. Engl. J. Med. 321: 1080–1085
Acknowledgements
The TRAF expression plasmid and anti-HA antibody HA-11 were generous gifts from Bill Sugden. The TK-lacZ reporter was the gift of Brad Olwin. This work was supported by NIH CA-64610 and AI-01537 grants to JM Martin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coffin III, W., Erickson, K., Hoedt-Miller, M. et al. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain. Oncogene 20, 5313–5330 (2001). https://doi.org/10.1038/sj.onc.1204689
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204689
Keywords
This article is cited by
-
The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies
Systematic Reviews (2015)
-
Nucleotide Sequences and Functions of the Epstein-Barr Virus Latent Membrane Protein 1 Genes Isolated from Salivary Gland Lymphoepithelial Carcinomas
Virus Genes (2005)
-
Epstein-barr virus latent membrane protein 1: Structure and functions
Journal of Biomedical Science (2003)